Edoc Acquisition Resultados de beneficios anteriores

Pasado controles de criterios 0/6

Edoc Acquisitionhan disminuido a un ritmo medio anual de -7.6%, mientras que en el sector Capital Markets los beneficios se situaron en growing a un ritmo anual de 12.1%.

Información clave

-7.6%

Tasa de crecimiento de los beneficios

46.7%

Tasa de crecimiento del BPA

Crecimiento de la industria Capital Markets	10.3%
Tasa de crecimiento de los ingresos	n/a
Rentabilidad financiera	n/a
Margen neto	n/a
Última actualización de beneficios	30 Sep 2023

Actualizaciones de resultados anteriores recientes

No hay actualizaciones

Recent updates

Edoc Acquisition announces termination of deal with Calidi Biotherapeutics

Aug 15

Desglose de ingresos y gastos
Beta

Cómo gana y gasta dinero Edoc Acquisition. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).

Historial de beneficios e ingresos

NasdaqCM:ADOC Ingresos, gastos y beneficios (USD Millions)
Fecha	Beneficios	Gastos G+A
30 Sep 23	-2	2
30 Jun 23	-2	2
31 Mar 23	-4	2
31 Dec 22	-8	3
30 Sep 22	-7	2
30 Jun 22	-7	3
31 Mar 22	-6	3
31 Dec 21	-1	2

Ingresos de calidad: ADOC actualmente no es rentable.

Margen de beneficios creciente: ADOC actualmente no es rentable.

Análisis del flujo de caja libre vs. Beneficios

Análisis del crecimiento de los beneficios en el pasado

Tendencia de beneficios: No hay datos suficientes para determinar si la tasa de crecimiento interanual de los beneficios de ADOC ha sido positiva en los últimos 5 años.

Acelerando crecimiento: No se puede comparar el crecimiento de los beneficios de ADOC en el último año con su media de 5 años, ya que actualmente no es rentable.

Beneficios vs. Industria: ADOC no es rentable, por lo que resulta difícil comparar el crecimiento de sus beneficios en el último año con el del sector Capital Markets (2.4%).

Rentabilidad financiera

Alto ROE: ADOCEl pasivo de la empresa supera su activo, por lo que es difícil calcular su Rentabilidad de los fondos propios.

Rentabilidad económica

Rendimiento del capital invertido

Descubre empresas con buenos resultados en el pasado

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Edoc Acquisition Resultados de beneficios anteriores

Pasado controles de criterios 0/6

Información clave

Actualizaciones de resultados anteriores recientes

Recent updates

EDOC Acquisition Files Form 15

Edoc Acquisition Intends to File Form 15

Australian Oilseeds Investments Pty Ltd. completed the acquisition of Edoc Acquisition Corp. (NasdaqCM:ADOC) from American Physicians LLC, Harradan Circle Investors, LP, Mint Tower Capital Management B.V. and others in a reverse merger transaction.

Edoc Acquisition Corp. announced that it has received $0.25 million in funding

Edoc Acquisition Corp. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q

Edoc Acquisition Corp. announced that it has received $0.25 million in funding

Edoc Acquisition Receives a Notice from the Staff of the Listing Qualifications Department of the Nasdaq Stock Market

Edoc Acquisition Corp. announced delayed 10-Q filing

Edoc Acquisition Corp. Receives Non-Compliance Letter from Nasdaq

New major risk - Financial position

Edoc Acquisition Corp. announced that it expects to receive $7 million in funding from Australian Oilseeds Investments Pty Ltd.

New major risk - Financial position

Edoc Acquisition Corp. Auditor Raises 'Going Concern' Doubt

Edoc Acquisition Submits A Plan of Compliance to the Nasdaq with Respect to the Annual Meeting Deficiency

Edoc Acquisition Receives Non-Compliance Notice from Nasdaq

High number of new and inexperienced directors

Australian Oilseeds Investments Pty Ltd. entered into a definitive Business Combination Agreement to acquire Edoc Acquisition Corp. (NasdaqCM:ADOC) in a reverse merger transaction.

Edoc Acquisition Corp. Appoints Yan Michael Li and Jintao Zheng as Independent Directors

Edoc Acquisition Corp. Announces Board Changes

Edoc Acquisition announces termination of deal with Calidi Biotherapeutics

EDOC Acquisition Receives A Deficiency Letter from the Listing Qualifications Department of the Nasdaq Stock Market Regarding Market Value of Listed Securities Requirement

Calidi Biotherapeutics, Inc. entered into a definitive agreement to acquire Edoc Acquisition Corp. (NasdaqCM:ADOC) from American Physicians LLC and others for $400 million in a reverse merger transaction.

Edoc Acquisition Corp. (NasdaqCM:ADOC) entered into an agreement to acquire Calidi Biotherapeutics, Inc. from WON & PARTNERS Limited for $400 million.

Edoc Acquisition Corp. Regains Nasdaq Compliance Following Filing of Delayed Annual Report and Quarterly Report

Edoc Acquisition Regains Nasdaq Compliance Following Filing of Delayed Annual Report and Quarterly Report

Edoc Acquisition Corp. announced delayed 10-Q filing

Edoc Acquisition Corp. announced delayed annual 10-K filing

Desglose de ingresos y gastos
Beta

Historial de beneficios e ingresos

Análisis del flujo de caja libre vs. Beneficios

Análisis del crecimiento de los beneficios en el pasado

Rentabilidad financiera

Rentabilidad económica

Rendimiento del capital invertido

Descubre empresas con buenos resultados en el pasado

Edoc Acquisition Resultados de beneficios anteriores

Pasado controles de criterios 0/6

Información clave

Actualizaciones de resultados anteriores recientes

Recent updates

EDOC Acquisition Files Form 15

Edoc Acquisition Intends to File Form 15

Australian Oilseeds Investments Pty Ltd. completed the acquisition of Edoc Acquisition Corp. (NasdaqCM:ADOC) from American Physicians LLC, Harradan Circle Investors, LP, Mint Tower Capital Management B.V. and others in a reverse merger transaction.

Edoc Acquisition Corp. announced that it has received $0.25 million in funding

Edoc Acquisition Corp. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q

Edoc Acquisition Corp. announced that it has received $0.25 million in funding

Edoc Acquisition Receives a Notice from the Staff of the Listing Qualifications Department of the Nasdaq Stock Market

Edoc Acquisition Corp. announced delayed 10-Q filing

Edoc Acquisition Corp. Receives Non-Compliance Letter from Nasdaq

New major risk - Financial position

Edoc Acquisition Corp. announced that it expects to receive $7 million in funding from Australian Oilseeds Investments Pty Ltd.

New major risk - Financial position

Edoc Acquisition Corp. Auditor Raises 'Going Concern' Doubt

Edoc Acquisition Submits A Plan of Compliance to the Nasdaq with Respect to the Annual Meeting Deficiency

Edoc Acquisition Receives Non-Compliance Notice from Nasdaq

High number of new and inexperienced directors

Australian Oilseeds Investments Pty Ltd. entered into a definitive Business Combination Agreement to acquire Edoc Acquisition Corp. (NasdaqCM:ADOC) in a reverse merger transaction.

Edoc Acquisition Corp. Appoints Yan Michael Li and Jintao Zheng as Independent Directors

Edoc Acquisition Corp. Announces Board Changes

Edoc Acquisition announces termination of deal with Calidi Biotherapeutics

EDOC Acquisition Receives A Deficiency Letter from the Listing Qualifications Department of the Nasdaq Stock Market Regarding Market Value of Listed Securities Requirement

Calidi Biotherapeutics, Inc. entered into a definitive agreement to acquire Edoc Acquisition Corp. (NasdaqCM:ADOC) from American Physicians LLC and others for $400 million in a reverse merger transaction.

Edoc Acquisition Corp. (NasdaqCM:ADOC) entered into an agreement to acquire Calidi Biotherapeutics, Inc. from WON & PARTNERS Limited for $400 million.

Edoc Acquisition Corp. Regains Nasdaq Compliance Following Filing of Delayed Annual Report and Quarterly Report

Edoc Acquisition Regains Nasdaq Compliance Following Filing of Delayed Annual Report and Quarterly Report

Edoc Acquisition Corp. announced delayed 10-Q filing

Edoc Acquisition Corp. announced delayed annual 10-K filing

Desglose de ingresos y gastosBeta

Historial de beneficios e ingresos

Análisis del flujo de caja libre vs. Beneficios

Análisis del crecimiento de los beneficios en el pasado

Rentabilidad financiera

Rentabilidad económica

Rendimiento del capital invertido

Descubre empresas con buenos resultados en el pasado

Desglose de ingresos y gastos
Beta